Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
50
Impuestos
34
Contabilidad
27
Impuesto al valor agregado
17
Derecho fiscal
14
Impuesto sobre el valor agregado
12
Impuestos sobre la renta
12
Estudio y enseñanza
5
leyes y legislación
5
Administración
2
Honorarios profesionales
2
Impuestos sobre bienes inmuebles
2
Leyes y Legislación
2
México
2
Retención de impuestos
2
Administración y procedimientos de impuestos
1
Análisis transaccional
1
Arte
1
Asociaciones
1
Derecho
1
Duetos vocales sacros y conjunto instrumental
1
Economía
1
Empresas
1
Enseñanza programada
1
Estudiantes extranjeros
1
Finanzas
1
Fisicoquímica
1
Francés
1
Historia y crítica
1
Impuesto a los depósitos en efectivo
1
-
3661“…A diagnosis of ascending colon cancer (cT4aN2aM1a [H3]: TNM classification 8th edition) stage IVa with RAS/BRAF wild-type mutation was made (four liver metastases up to 60 mm in diameter were observed in both lobes). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3662por Kennedy, Philippa R., Vallera, Daniel A., Ettestad, Brianna, Hallstrom, Caroline, Kodal, Behiye, Todhunter, Deborah A., Bendzick, Laura, Hinderlie, Peter, Walker, Joshua T., Pulkrabek, Brittany, Pastan, Ira, Kratzke, Robert A., Fujioka, Naomi, Miller, Jeffrey S., Felices, Martin“…Six patients had earlier stage NSCLC (I-IVA) and eight had highly advanced NSCLC (IVB). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3663“…METHODS: Patients with pathologically confirmed thoracic esophageal squamous cell carcinoma and at clinical T1-2N1-3M0 or T3-4aN0-3M0 (stage II–IVA) according to the eighth edition of American Joint Committee on Cancer staging will be allocated to receive neoadjuvant radiotherapy (41.4 Gy with 23 fractions to planning target volume) with concurrent chemotherapy (albumin-bound paclitaxel, 100 mg/m(2), once weekly for five weeks; carboplatin, area under the curve of 2 mg/mL/min, once weekly for five weeks) plus tislelizumab monotherapy sequentially (200 mg every three weeks for three cycles, beginning from the first to the 14th day after the end of radiotherapy). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3664por Igbinosa, Etinosa O., Beshiru, Abeni, Igbinosa, Isoken H., Ogofure, Abraham G., Ekundayo, Temitope C., Okoh, Anthony I.“…All the staphylococcal cassette chromosome mec (SCCmec) IVa and SCCmec V positive isolates harboured the Panton-Valentine Leukocidin Gene (PVL). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3665por Wang, Shu, Xu, Guanghui, Li, Mengbin, Zheng, Jiyang, Wang, Yuhao, Feng, Xiangying, Luo, Jialin, Wang, Shibo, Liu, Huan, Duan, Weiming, Zhang, Hushan, Huang, Depei, Zhao, Feilong, Nie, Yongzhan, Yang, Jianjun“…METHODS: We enrolled and randomly assigned patients with stage II-IVa ESCC to two study treatments: camrelizumab combined with docetaxel, cisplatin and fluorouracil (DCF) regimen and DCF regimen alone. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3666por Murakami, Naoya, Watanabe, Miho, Uno, Takashi, Sekii, Shuhei, Tsujino, Kayoko, Kasamatsu, Takahiro, Machitori, Yumiko, Aoshika, Tomomi, Kato, Shingo, Hirowatari, Hisako, Kaneyasu, Yuko, Nakagawa, Tomio, Ikushima, Hitoshi, Ando, Ken, Murata, Masumi, Yoshida, Ken, Yoshioka, Hiroto, Murata, Kazutoshi, Ohno, Tatsuya, Okonogi, Noriyuki, Saito, Anneyuko I., Ichikawa, Mayumi, Okuda, Takahito, Tsuchida, Keisuke, Sakurai, Hideyuki, Yoshimura, Ryoichi, Yoshioka, Yasuo, Yorozu, Atsunori, Kunitake, Naonobu, Okamoto, Hiroyuki, Inaba, Koji, Kato, Tomoyasu, Igaki, Hiroshi, Itami, Jun“…METHODS: Patients with FIGO stage IB2-IVA uterine cervical cancer pretreatment width of which was ≥5 cm measured by magnetic resonance imaging were eligible for this clinical trial. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3667por Chen, Kuan-Chih, Huang, Yen-Hsiang, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Chang, Gee-Chen, Yang, Tsung-Ying“…Patients with stage IVB disease were more likely to have a high baseline NLR than those with stage IIIB-IVA (33.9% vs 15.1%, P = 0.029). Other patients’ characteristics did not correlate with the baseline NLR significantly. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3668por Reinders, Floris C. J., Stijnman, Peter R. S., de Ridder, Mischa, Doornaert, Patricia A. H., Raaijmakers, Cornelis P. J., Philippens, Marielle E. P.“…The weekly delineations of elective lymph nodes inside the lymph node levels (Ib/II/III/IVa/V) were rigidly registered and analyzed regarding number and volume. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3669por Garrine, Marcelino, Costa, Sofia Santos, Messa, Augusto, Massora, Sérgio, Vubil, Delfino, Ácacio, Sozinho, Nhampossa, Tacilta, Bassat, Quique, Mandomando, Inacio, Couto, Isabel“…The 16 MRSA strains detected belonged to clones t064-ST612/CC8-SCCmecIVd (69%, 11/16), t008-ST8/CC8-SCCmecNT (25%, 4/16) and t5351-ST88/CC88-SCCmecIVa (6%, 1/16). Specific clonal lineages were associated with extended length of stay and high in-hospital mortality. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3670por Huang, Yingying, Sun, Jingjing, Li, Jun, Zhu, Dongwang, Dong, Minjun, Dou, Shengjin, Tang, Yong, Shi, Wentao, Sun, Qi, Zhao, Tongchao, Zhou, Zhihang, Zhou, Xinyu, Liu, Ying, Li, Jiang, Zhu, Guopei, Zhang, Ding, Chen, Yanan, Zhu, Qi, Ju, Wutong, Zhong, Laiping“…PATIENTS AND METHODS: A prospective trial of NAICT with toripalimab (PD-1 inhibitor) and albumin paclitaxel/cisplatin (TTP) was conducted in patients with clinical stage III and IVA OSCC. Intravenous albumin paclitaxel (260 mg/m(2)), cisplatin (75 mg/m(2)), and toripalimab (240 mg) were given in sequence on day 1 of each 21 day cycle for two cycles, followed by radical surgery and risk-adapted adjuvant (chemo)radiotherapy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3671por Bonaccorsi-Riani, Eliano, Daudré-Vignier, Victoria, Ciccarelli, Olga, Coubeau, Laurent, Iesari, Samuele, Castanares-Zapatero, Diego, Collienne, Christine, Annet, Laurence, Danse, Etienne, Balligand, Jean-Luc, Lefebvre, Chantal, Dieu, Audrey, Benoit, Loïc, Reding, Raymond“…No Clavien-Dindo class IVa or b complications or donor mortality (Clavien-Dindo class V) were observed. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3672por Chen, Xianyan, Tian, Xiaoman, Zhang, Xuanwei, Deng, Qianyue, Wang, Min, Zhou, Xiaojuan, Xu, Yong, Zhou, Lin, Zou, Bingwen, Liu, Yongmei, Ao, Rui, Lu, You, Gong, Youling“…Logistic stepwise regression was used to identify variables associated with G4 lymphopenia, and the final model consisted of stage‐IVA (p = 0.017), platelet‐to‐lymphocyte ratio during CCRT (p = 0.008), Heart V50 (p = 0.046), and PV(30) (p = 0.048). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3673por Merkely, Béla, Hatala, Robert, Wranicz, Jerzy K, Duray, Gábor, Földesi, Csaba, Som, Zoltán, Németh, Marianna, Goscinska-Bis, Kinga, Gellér, László, Zima, Endre, Osztheimer, István, Molnár, Levente, Karády, Júlia, Hindricks, Gerhard, Goldenberg, Ilan, Klein, Helmut, Szigeti, Mátyás, Solomon, Scott D, Kutyifa, Valentina, Kovács, Attila, Kosztin, Annamária“…METHODS: In this multicentre, randomized, controlled trial, 360 symptomatic (New York Heart Association Classes II–IVa) HFrEF patients with a pacemaker or implantable cardioverter defibrillator (ICD), high RVP burden ≥ 20%, and a wide paced QRS complex duration ≥ 150 ms were randomly assigned to receive CRT-D upgrade (n = 215) or ICD (n = 145) in a 3:2 ratio. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3674por Oza, A. M., Ganesan, T. S., Dorreen, M., Johnson, P. W., Waxman, J., Gregory, W., Lim, J., Wright, J., Dadiotis, L., Barbounis, V.“…A total of 164 consecutive adults with newly confirmed stage IIIB, IVA or IVB Hodgkin's disease (HD) commenced cyclical combination chemotherapy comprising mustine, vinblastine, prednisolone and procarbazine (MVPP) every 6 weeks (145 patients) or minor variants (19) at St Bartholomew's Hospital between 1968 and 1984. …”
Publicado 1992
Enlace del recurso
Enlace del recurso
Texto -
3675Publicado 1992“…These responses were enhanced by LBP and inhibited by mAb 60b. dLPS and its synthetic lipid A counterpart, LA-14-PP (also known as lipid Ia, lipid IVa, or compound 406) strongly inhibited LPS-induced NF- kappa B and IL-1 beta, yet neither antagonist inhibited the uptake of LPS via CD14. dLPS did not inhibit NF-kappa B responses to tumor necrosis factor (TNF) alpha or phorbol ester. …”
Enlace del recurso
Enlace del recurso
Texto -
3676“…We have previously described elevations in β(III) and β(IVa) isotypes in estramustine and paclitaxel resistant human prostate carcinoma cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3677por Deslandes, Vincent, Denicourt, Martine, Girard, Christiane, Harel, Josée, Nash, John HE, Jacques, Mario“…Our results indicate that, for example, gene apxIVA from an operon coding for RTX toxin ApxIV is highly up-regulated in vivo, and that two genes from the operon coding for type IV fimbriae (APL_0878 and APL_0879) were also up-regulated. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3678“…Presenting stages were stage IIB in 62, stage III in 197, and stage IVA/B in 111 patients. All patients except for 36 patients with cervical lymphadenopathy of 4 cm or less in diameter received 2 cycles of cisplatin-based neoadjuvant chemotherapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3679“…In addition to multiple sulfatase deficiency, the differential diagnosis should also include other forms of MPS (MPS I, II IVA, VII), sialidosis and mucolipidosis. Before enzyme replacement therapy (ERT) with galsulfase (Naglazyme(®)), clinical management was limited to supportive care and hematopoietic stem cell transplantation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3680por Izquierdo, Conchita, Oviedo, Manuel, Ruiz, Laura, Sintes, Xavier, Vera, Isabel, Nebot, Manel, Bayas, Jose-María, Carratalà, Jordi, Varona, Wenceslao, Sousa, Dolores, Celorrio, Jose-Miguel, Salleras, Luis, Domínguez, Angela“…Socioeconomic status was measured using both individual and community data: occupation [categorized in six social groups (I, II, III, IVa, IVb and V)], educational level (≤ primary level or ≥ secondary level) and disposable family income of the municipality or district of residence [>12,500 € (high municipality family income) and ≤12,500 € (low municipality family income)]. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto